New blood test detects 90% of aggressive prostate cancer cases, beating current screenings

A new test could make it easier to detect high-risk prostate cancer cases earlier.

The blood test, called Stockholm3, is showing promise in clinical trials, beating out the traditional, standard prostate-specific antigen (PSA) test.

In a new study published in the Annals of Internal Medicine, researchers from the Karolinska Institutet in Sweden studied the test’s efficacy in more than 12,000 men – mostly Swedish or European – aged 50 to 74.

NEW PROSTATE CANCER TEST PINPOINTS DISEASE BETTER THAN PSA OPTION...